Filter posts

Debunking a Common Myth on Out-of-Pocket Costs

The facts continue to show that, when it comes to prescription drug costs, the country …

Co-Pay Accumulator Programs Are a Bad Deal for Patients

As we see time and time again, health insurance providers and pharmacy benefit managers (PBMs) …

New Report Offers “Distorted View” of Biopharma Industry

This week, the Minority Staff of the U.S. Senate Committee on Finance released a report …

Drug Importation and Its Dangerous Side Effects

Writing for the National Review, Sally Pipes of the Pacific Research Institute authors a stark …

BIO Communications Responds to Misleading Op-Ed about Medicaid Drug Costs

This week, Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center authored an op-ed about the …

Fact Checking Misleading Claims about Drug Costs

In a series of new blogs, AHIP once again paints drug manufacturers as the culprit …

Is Your Emergency Worth It? Let’s Ask Your Insurer…

Imagine that it is 2AM and the pain is so severe that you cannot move. …

Why a New Study on Drug Costs Misses the Mark

BIO President and CEO Jim Greenwood recently described 2017 as a “transformative year in medicine.” …

New Infographic Highlights the Remarkable Success of Medicare Part D

Since 2006, the Medicare prescription drug program – known as Medicare Part D – has …

Pharmacy Revenues Decline, Thanks to Cheaper Medicines

We’ve been saying it for some time, and the numbers speak for themselves: spending on …